First report on the detection of OXA-48 β-lactamase gene in Escherichia coli and Pseudomonas aeruginosa co-infection isolated from a patient in a Tertiary Care Hospital in Assam
Dear Editor, A 22-year-old female, in her first trimester of pregnancy, undergoing broad spectrum antibiotic treatment was admitted to the Intensive Care Unit of a Tertiary Care Hospital in Assam was diagnosed with aspiration pneumonia including acute respiratory distress syndrome. Urine culture, on day 7, yielded Escherichia coli and Pseudomonas aeruginosa. Both isolates were resistant to amikacin, norfloxacin, tigecycline, cefepime, ceftriaxone, cefoperazone, amoxyclav and cefoperazone (latter two antibiotics tested for E. coli only). From the previous hospitalisation, the tracheal aspirate yielded Klebsiella sps. with a broad spectrum resistance and was treated with Dorikem (500 mg/8 h, i/v). The isolates were tested for possible resistance mechanisms -extended-spectrum β-lactamase (ESBL) and carbapenemase production was tested by Double Disc Synergy test, [1] Modified Hodge test [1] and combined double-disk test. [2] Both isolates, negative for metallo-β-lactamase production, showed complete resistance to cefotaxime, ceftazidime, aztreonam, oxacillin, cefoxitin, imipenem, doripenem, ertapenem and meropenem. Polymerase chain reaction (PCR) analysis revealed the presence of CTX-M, TEM and SHV in E. coli while only TEM was detected in Pseudomonas isolates [ Figure 1 ]. PCR failed the detection of NDM, VIM, IMP and KPC which was indicated through phenotypic tests. However, OXA-48 was detected in both the isolates using primers published elsewhere. [3] Strain J53 pMG298 (CTX-M-15) and J53-1 R455 (OXA-1) provided by Dr. George A. Jacoby, Lahey Clinic Medical Centre, Klebsiella pneumoniae ATCC 700603 (SHV-18), clinical isolates each containing TEM and NDM detected by uniplex PCR followed by sequence confirmation were used as representative positive controls and E. coli ATCC 25922 was used as the negative control. The OXA positive PCR amplicons were sequence confirmed and compared to the Genbank database for confirmation of correct amplification of target gene. Plasmid analysis of both the isolates and their transference ability was tested using E. coli J53 azide resistant as a recipient for conjugation experiments and as a plasmid-free comparison. [4] With similar resistance profile except for imipenem, PCR detection of both conjugant showed the presence of OXA-48 and CTX-M, TEM and SHV in the E. coli, however, TEM was not detected in the P. aeruginosa isolate. Electrophoresis revealed the presence of a ~60 Kb plasmid in the clinical isolates as well as in the conjugants. This conjugative plasmid has previously associated with the dissemination of this resistant trait. [3] The isolates were intermediately susceptible to piperacillin but susceptible to polymyxin -B; the patient was thus treated with Pipzo (i/v) 4 × 250 mg/day. The patient, due to the critical condition from respiratory dysfunction, did not survive.
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Production of OXA with co-prevalence of ESBL genes in the clinical isolates emphasises on the need for proper regulatory policies for the control of these antibiotic resistant isolates in the region and nationwide, guided antibiotic administration to patients to prevent misuse thus spread of resistance in bacteria.
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